← Back to Search
Codelivery Of Doxorubicin And Triptolide With Reduction-sensitive Lipid–polymer Hybrid Nanoparticles For In Vitro And In Vivo Synergistic Cancer Treatment
B. Wu, Shuting Lu, Liu-jie Zhang, R. Zhuo, H. Xu, Shiwen Huang
Published 2017 · Chemistry, Medicine
Download PDFAnalyze on Scholarcy
Codelivery is a promising strategy to overcome the limitations of single chemotherapeutic agents in cancer treatment. Despite progress, codelivery of two or more different functional drugs to increase anticancer efficiency still remains a challenge. Here, reduction-sensitive lipid–polymer hybrid nanoparticles (LPNPs) drug delivery system composed of monomethoxy-poly(ethylene glycol)-S-S-hexadecyl (mPEG-S-S-C16), soybean lecithin, and poly(D,L-lactide-co-glycolide) (PLGA) was used for codelivery of doxorubicin (DOX) and a Chinese herb extract triptolide (TPL). Hydrophobic DOX and TPL could be successfully loaded in LPNPs by self-assembly. More importantly, drug release and cellular uptake experiments demonstrated that the two drugs were reduction sensitive, released simultaneously from LPNPs, and taken up effectively by the tumor cells. DOX/TPL-coloaded LPNPs (DOX/TPL-LPNPs) exhibited a high level of synergistic activation with low combination index (CI) in vitro and in vivo. Moreover, the highest synergistic therapeutic effect was achieved at the ratio of 1:0.2 DOX/TPL. Further experiments showed that TPL enhanced the uptake of DOX by human oral cavity squamous cell carcinoma cells (KB cells). Overall, DOX/TPL-coencapsulated reduction-sensitive nanoparticles will be a promising strategy for cancer treatment.
This paper references
Triptolide exerts anti-tumor effect on oral cancer and KB cells in vitro and in vivo.
Y. Chen (2009)
Single-step assembly of DOX/ICG loaded lipid--polymer nanoparticles for highly effective chemo-photothermal combination therapy.
Mingbin Zheng (2013)
Multi-drug delivery nanocarriers for combination therapy
Suresh Gadde (2015)
Polymer–lipid hybrid nanoparticles with reduction-triggered release for improved antitumor efficiency
C. Cui (2013)
Novel CD44 receptor targeting multifunctional “nano-eggs” based on double pH-sensitive nanoparticles for co-delivery of curcumin and paclitaxel to cancer cells and cancer stem cells
D. Chen (2015)
Triptolide induces apoptotic cell death of multiple myeloma cells via transcriptional repression of Mcl-1.
T. Nakazato (2014)
Triptolide synergistically enhances temozolomide-induced apoptosis and potentiates inhibition of NF-κB signaling in glioma initiating cells.
K. Sai (2014)
Indocyanine green loaded lipid-polymer nanoparticles for cancer imaging and therapy
Mingbin Zheng (2016)
Telodendrimer nanocarrier for co-delivery of paclitaxel and cisplatin: A synergistic combination nanotherapy for ovarian cancer treatment.
Liqiong Cai (2015)
Erratum: Synergistic drug combinations tend to improve therapeutically relevant selectivity
J. Lehar (2009)
Combination treatment with triptolide and hydroxycamptothecin synergistically enhances apoptosis in A549 lung adenocarcinoma cells through PP2A-regulated ERK, p38 MAPKs and Akt signaling pathways
G. Meng (2015)
Self-assembled lipid--polymer hybrid nanoparticles: a robust drug delivery platform.
L. Zhang (2008)
Folate-containing reduction-sensitive lipid-polymer hybrid nanoparticles for targeted delivery of doxorubicin.
B. Wu (2015)
PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery.
J. M. Chan (2009)
Bioactive constituents from toxic seed plants in China
Jing Qu (2013)
Cellular uptake, intracellular trafficking, and antitumor efficacy of doxorubicin-loaded reduction-sensitive micelles.
C. Cui (2013)
iRGD decorated lipid-polymer hybrid nanoparticles for targeted co-delivery of doxorubicin and sorafenib to enhance anti-hepatocellular carcinoma efficacy.
J. Zhang (2016)
Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cells
W. Fiskus (2017)
Improving drug accumulation and photothermal efficacy in tumor depending on size of ICG loaded lipid-polymer nanoparticles.
P. Zhao (2014)
Synthesis, characterization and bifunctional applications of bidentate silver nanoparticle assisted single drop microextraction as a highly sensitive preconcentrating probe for protein analysis
L. Shastri (2015)
Triptolide and tripdiolide, novel antileukemic diterpenoid triepoxides from Tripterygium wilfordii.
S. M. Kupchan (1972)
Lipid-Polymer Nanoparticles for Folate-Receptor Targeting Delivery of Doxorubicin.
Mingbin Zheng (2015)
Synergistic Combination of Gemcitabine and Dietary Molecule Induces Apoptosis in Pancreatic Cancer Cells and Down Regulates PKM2 Expression
Archana Pandita (2014)
Polymeric micelles as drug delivery vehicles
Z. Ahmad (2014)
Abstract B119: Triptolide abrogates expression of the Met and epidermal growth factor receptors in pancreatic cancer
V. Sangwan (2015)
Tumor-targeting dual peptides-modified cationic liposomes for delivery of siRNA and docetaxel to gliomas.
Z. Yang (2014)
Triptolide induces Bcl-2 cleavage and mitochondria dependent apoptosis in p53-deficient HL-60 cells.
Chi-Keung Wan (2006)
Triptolide inhibits ovarian cancer cell invasion by repression of matrix metalloproteinase 7 and 19 and upregulation of E-cadherin
H. Zhao (2012)
Triptolide: structural modifications, structure-activity relationships, bioactivities, clinical development and mechanisms.
Zhao-Li Zhou (2012)
In vivo prevention of arterial restenosis with paclitaxel-encapsulated targeted lipid–polymeric nanoparticles
J. M. Chan (2011)
Co-delivery of doxorubicin and Bcl-2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in multidrug-resistant cancer cells.
A. M. Chen (2009)
Two-component reduction-sensitive lipid-polymer hybrid nanoparticles for triggered drug release and enhanced in vitro and in vivo anti-tumor efficacy.
Liu-jie Zhang (2016)
Synergistic co-delivery of doxorubicin and paclitaxel using multi-functional micelles for cancer treatment.
Hoang Hanh Phuoc Duong (2013)
Synergistic effect of triptolide combined with 5-fluorouracil on colon carcinoma
X. Tang (2007)
Synergistic anticancer activity of triptolide combined with cisplatin enhances apoptosis in gastric cancer in vitro and in vivo.
C. Li (2012)
Self-assembled hybrid nanoparticles for targeted co-delivery of two drugs into cancer cells.
Fujian Huang (2014)
Protein-loaded PLGA–PEO blend nanoparticles: encapsulation, release and degradation characteristics
M. J. Santander-Ortega (2010)
Lipid-coated polymeric nanoparticles for cancer drug delivery
G. Borges (2018)
PLGA/polymeric liposome for targeted drug and gene co-delivery.
H. Wang (2010)
Co-delivery of doxorubicin and paclitaxel by PEG-polypeptide nanovehicle for the treatment of non-small cell lung cancer.
Shixian Lv (2014)
Tumor-penetrating codelivery of siRNA and paclitaxel with ultrasound-responsive nanobubbles hetero-assembled from polymeric micelles and liposomes.
T. Yin (2014)
Cancer-specific enhancement of cisplatin-induced cytotoxicity with triptolide through an interaction of inactivated glycogen synthase kinase-3β with p53
Y. Matsui (2008)
Recent trends in nano-based drug delivery systems for efficient delivery of phytochemicals in chemotherapy
A. P. Subramanian (2016)
This paper is referenced by
MRI-guided targeting delivery of doxorubicin with reduction-responsive lipid-polymer hybrid nanoparticles
B. Wu (2017)
Cisplatin and Ce6 loaded polyaniline nanoparticles: An efficient near-infrared light mediated synergistic therapeutic agent.
Chaoqun You (2019)
Inhalable hybrid nanocarriers for respiratory disorders
P. Maurya (2020)
The effects of TPL-PEI-CyD on suppressing performance of MCF-7 stem cells.
Y. Zhu (2020)
Redox-sensitive nanoscale drug delivery systems for cancer treatment.
Elaheh Mirhadi (2020)
Broad targeting of triptolide to resistance and sensitization for cancer therapy.
Zhen-yan Hou (2018)
A Mechanistic Overview of Triptolide and Celastrol, Natural Products from Tripterygium wilfordii Hook F
Shaoru Chen (2018)
Co-delivery system of chemotherapy drugs and active ingredients from natural plants: a brief overview of preclinical research for cancer treatment
Pu Guo (2020)
Synergistic effect of all-trans-retinal and triptolide encapsulated in an inflammation-targeted nanoparticle on collagen-induced arthritis in mice.
P. Li (2019)
Magnetic And pH Dual-Responsive Nanoparticles For Synergistic Drug-Resistant Breast Cancer Chemo/Photodynamic Therapy
D. Wang (2019)
Polymeric Co-Delivery Systems in Cancer Treatment: An Overview on Component Drugs’ Dosage Ratio Effect
Jiayi Pan (2019)
Triptolide and Its Derivatives as Cancer Therapies.
Pawan Noel (2019)
Threatening cancer with nanoparticle aided combination oncotherapy
Shruti Rawal (2019)
A novel liposome-polymer hybrid nanoparticles delivering a multi-epitope self-replication DNA vaccine and its preliminary immune evaluation in experimental animals☆☆☆
Zhangting Zhao (2020)
Toxicity of Doxorubicin (Dox) to different experimental organ systems
A. Pugazhendhi (2018)
Perspectives About Self-Immolative Drug Delivery Systems.
Rodrigo Vieira Gonzaga (2020)
Redox Nano-Architectures: Perspectives and Implications in Diagnosis and Treatment of Human Diseases.
Shamim Akhtar Sufi (2019)
Recent advances in co-delivery systems based on polymeric nanoparticle for cancer treatment
M. Afsharzadeh (2018)
Improving breast cancer therapy using doxorubicin loaded solid lipid nanoparticles: Synthesis of a novel arginine-glycine-aspartic tripeptide conjugated, pH sensitive lipid and evaluation of the nanomedicine in vitro and in vivo.
G. Zheng (2019)
Effective delivery of hydrophobic drugs to breast and liver cancer cells using a hybrid inorganic nanocarrier: A detailed investigation using cytotoxicity assays, fluorescence imaging and flow cytometry
D. C. Manatunga (2018)
Synergistic combination therapy of lung cancer using paclitaxel- and triptolide-coloaded lipid–polymer hybrid nanoparticles
J. Liu (2018)
Triptolide Suppresses Growth of Breast Cancer by Targeting HMGB1 in Vitro and in Vivo.
W. Jiang (2019)
Pharmaceutical Dispersion Techniques for Dissolution and Bioavailability Enhancement of Poorly Water-Soluble Drugs
X. Zhang (2018)
Therapeutic applications and delivery systems for triptolide
J. Viegas (2020)
Evaluation of methotrexate-conjugated gadolinium(III) for cancer diagnosis and treatment
D. Xu (2018)
Effective delivery of hydrophobic drugs to breast (MCF-7) and Liver (HepG2) cancer cells: A detailed investigation using Cytotoxicity assays, fluorescence imaging and flow cytometry
D. C. Manatunga (2018)
pH-triggered charge-reversal and redox-sensitive drug-release polymer micelles codeliver doxorubicin and triptolide for prostate tumor therapy
C. Xu (2018)
Huayu Pill (化瘀丸) Promotes Fluorescent Doxorubicin Delivery to Tumors in Mouse Model of Lung Cancer
Lei Gao (2020)
Zebrafish, a model to develop nanotherapeutics that control neutrophils response during inflammation.
J. P. García-López (2019)
Beyond liposomes: Recent advances on lipid based nanostructures for poorly soluble/poorly permeable drug delivery.
M. C. Teixeira (2017)